MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-12-31, VTGN has $65,056K in assets. $14,136K in debts. $47,371K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
467.48%
Cash Ratio
350.14%
Debt to Asset Ratio
21.73%
Assets Breakdown
    • Cash and cash equivalents
    • Marketable securities
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued expenses
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
47,371 62,786 48,985
Marketable securities
14,399 14,389 14,195
Prepaid expenses and other current assets
1,475 1,759 3,536
Total current assets
63,245 78,934 66,716
Property and equipment, net
480 516 530
Right-of-use asset - operating lease
939 1,074 1,206
Other assets
392 405 472
Total assets
65,056 80,929 68,924
Accounts payable
1,280 1,831 486
Accrued expenses
9,254 8,417 6,582
Note payable
379 658 933
Deferred revenue - current portion
1,999 2,141 2,514
Operating lease obligation - current portion
617 597 640
Total current liabilities
13,529 13,644 11,155
Deferred revenue - non-current portion
176 336 221
Operating lease obligation - non-current portion
431 610 783
Total liabilities
14,136 14,590 12,159
Common stock, 0.001 par value 325,000,000 shares authorized at december31, 2025 and march31, 2025 39,624,839 and 29,001,481 shares issued at december31, 2025 and march31, 2025, respectively
40 39 29
Additional paid-in capital
515,878 512,398 483,430
Treasury stock, at cost, 4,522 shares of common stock held at december31, 2025 and march31, 2025
3,968 3,968 3,968
Accumulated other comprehensive income
13 14 1
Accumulated deficit
-461,043 -442,144 -422,727
Total stockholders equity
50,920 66,339 56,765
Total liabilities and stockholders equity
65,056 80,929 68,924
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andother current assets$1,475K Marketable securities$14,399K Cash and cashequivalents$47,371K Other assets$392K Right-of-use asset -operating lease$939K Property and equipment,net$480K Total current assets$63,245K Total assets$65,056K Total liabilities andstockholders equity$65,056K Total stockholdersequity$50,920K Total liabilities$14,136K Accumulated deficit-$461,043K Treasury stock, at cost,4,522 shares of common...$3,968K Accumulated othercomprehensive income$13K Additional paid-in capital$515,878K Operating leaseobligation - non-current...$431K Deferred revenue -non-current portion$176K Total currentliabilities$13,529K Common stock, 0.001 parvalue 325,000,000...$40K Operating leaseobligation - current...$617K Deferred revenue -current portion$1,999K Note payable$379K Accrued expenses$9,254K Accounts payable$1,280K

Vistagen Therapeutics, Inc. (VTGN)

Vistagen Therapeutics, Inc. (VTGN)